Dynamic duo: Combination therapy reverses type 1 diabetes

Researchers have now carefully crafted a combination therapy that reverses recent-onset type 1 diabetes in 2 animal models of disease. By combining an oral with an intranasal therapy for type 1 diabetes that have individually shown beneficial, but limited, effects in previous studies, Matthias von Herrath and colleagues at the La Jolla Institute for Allergy and Immunology deliver a one-two punch, and prove that, in this case, 2 treatments work together better than one. The study appears online on April 20 in advance of print publication in the May issue of the Journal of Clinical Investigation.

In patients with type 1 diabetes, the autoimmune response destroys insulin-producing cells (beta cells) in pancreatic islets, thereby subjecting these individuals often children or young adults to a lifetime of insulin injections. To prevent disease, autoreactive immune cells need to be suppressed or eliminated without negative side-effects. One treatment strategy that has been shown to suppress beta cell killing is the delivery of an antibody against the CD3 molecule expressed on most T cells. This antibody promotes the function of regulatory T cells (Tregs), which put the brakes on an overaggressive immune response. However, chronic "body-wide" suppression of the immune system in this way puts patients at risk for malignancies or reactivation of dormant viral infections, consequently dampening enthusiasm for this monotherapeutic approach.

One of the critical questions that has remained is how do we prevent immune responses against only insulin-producing cells? Promising data in animal models has shown that it is possible to deliver beneficial immune modulatory molecules to the pancreatic islets by inducing islet antigenspecific Tregs. However, this intervention only appears effective early in the pre-diabetic stage.

In their JCI study, von Herrath and colleagues show that combination treatment with a low-dose, orally-delivered CD3epsilon-specific a

Contact: Brooke Grindlinger
Journal of Clinical Investigation

Page: 1 2

Related medicine news :

1. Dynamic sonography accurate in diagnosing muscle tears
2. Combination treatment stymies breast cancer growth
3. Combination therapy spares some head and neck patients from surgery
4. Combination of personality traits increases risk for heart disease
5. Combination therapy may improve survival for pancreatic cancer
6. Combination therapy with a monocloncal antibody and a vaccine leads to tumor rejection
7. Combination of three new, high-powered MRI systems at PENN is a first in the US
8. Combination of interventions can substantially reduce incidence of malaria in people with HIV
9. Combination therapy improves AIDS-related lymphoma outcome
10. Combination treatment for brain cancer not detrimental to patients quality of life
11. Combination microbicides protect monkeys against HIV-like virus

Post Your Comments:

(Date:7/17/2019)... ... July 17, 2019 , ... Dynamic Healthcare Systems, ... Advantage, Medicaid, and Marketplace programs is pleased to announce the introduction of an ... (EHR) integration at the point of care to providers and provider groups ...
(Date:7/17/2019)... ... , ... It took just several small incisions by St. Luke's University ... the nerves under Amber Walck’s scalp, and suddenly her two-year agony with migraines was ... debilitating headaches began without warning. About 39 million Americans suffer from migraines that ...
(Date:7/17/2019)... ... July 17, 2019 , ... Athena Software , ... services providers worldwide, has been awarded a California Multiple Award Schedules (CMAS) agreement ... for state and local government agencies in California by designating pre-approved suppliers from ...
(Date:7/17/2019)... DIEGO (PRWEB) , ... July 17, 2019 , ... People ... become parents. Every Intended Parents’ story differs , but, in addition to creating ... Surrogate. , Across the globe, more and more Intended Parents are electing to have ...
(Date:7/17/2019)... ... July 17, 2019 , ... The Coalition of ... announced that seven of its member Opioid Treatment Programs (OTPs) at 12 locations ... hepatitis C virus (HCV) with the goal of achieving better outcomes through telemedicine. ...
Breaking Medicine News(10 mins):
(Date:7/17/2019)... ... ... Soliant, a leading healthcare staffing provider and part of the Adecco Group, ... Beautiful Hospital in the U.S. In Soliant’s 10th annual top 20 contest, a record ... hospitals nominated. Supporters from across the country nominated and voted for facilities they felt ...
(Date:7/17/2019)... (PRWEB) , ... July 17, 2019 , ... The American ... APNA Board of Directors and 2020 Nominating Committee . Elected by psychiatric-mental health nurse ... APNA 33rd Annual Conference in New Orleans, LA, October 2-5, 2019. , ...
(Date:7/17/2019)... Ohio (PRWEB) , ... July 17, 2019 , ... ... pharmacies with an all-in-one solution needed to attract new customers, better engage existing ... healthcare partner to offer digital marketing services in tandem with an all-in-one platform. ...
Breaking Medicine Technology:
Cached News: